Business & Economy

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Source: Business News · Published

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength
Source: Business News

Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.

Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.

Read Original Source